Alva A - Search Results

1

Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer.

Smith DC, Daignault-Newton S, Grivas P, Reichert ZR, Hussain M, Cooney KA, Caram M, Alva A, Jacobson J, Yablon C, Mehra R, Escara-Wilke J, Shelley G, Keller ET. Smith DC, et al. Among authors: alva a. Clin Genitourin Cancer. 2020 Aug;18(4):332-339.e2. doi: 10.1016/j.clgc.2019.10.019. Epub 2020 Mar 7. Clin Genitourin Cancer. 2020. PMID: 32299729 Free PMC article. Clinical Trial.

2

Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium.

Alva A, Slovin S, Daignault S, Carducci M, Dipaola R, Pienta K, Agus D, Cooney K, Chen A, Smith DC, Hussain M. Alva A, et al. Invest New Drugs. 2012 Apr;30(2):749-57. doi: 10.1007/s10637-010-9573-5. Epub 2010 Nov 4. Invest New Drugs. 2012. PMID: 21049281 Free PMC article. Clinical Trial.

3

Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach.

Alva AS, Tallman CT, He C, Hussain MH, Hafez K, Montie JE, Smith DC, Weizer AZ, Wood D, Lee CT. Alva AS, et al. Cancer. 2012 Jan 1;118(1):44-53. doi: 10.1002/cncr.26240. Epub 2011 May 19. Cancer. 2012. PMID: 21598245 Free article.

4

The changing natural history of metastatic prostate cancer.

Alva A, Hussain M. Alva A, et al. Cancer J. 2013 Jan-Feb;19(1):19-24. doi: 10.1097/PPO.0b013e318281197e. Cancer J. 2013. PMID: 23337753 Review.

5

A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the bladder.

Grivas PD, Hussain M, Hafez K, Daignault-Newton S, Wood D, Lee CT, Weizer A, Montie JE, Hollenbeck B, Montgomery JS, Alva A, Smith DC. Grivas PD, et al. Among authors: alva a. Urology. 2013 Jul;82(1):111-7. doi: 10.1016/j.urology.2013.03.044. Epub 2013 May 21. Urology. 2013. PMID: 23706253 Clinical Trial.

6

Optimal pharmacotherapeutic management of hormone-sensitive metastatic prostate cancer.

Alva A, Hussain M. Alva A, et al. Drugs. 2013 Sep;73(14):1517-24. doi: 10.1007/s40265-013-0106-3. Drugs. 2013. PMID: 23959841 Review.

7

Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma.

Alva A, Daignault S, Smith DC, Hussain M. Alva A, et al. Invest New Drugs. 2014 Feb;32(1):188-94. doi: 10.1007/s10637-013-0054-5. Epub 2013 Dec 10. Invest New Drugs. 2014. PMID: 24318901 Free PMC article. Clinical Trial.

8

Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing.

Mehra R, Vats P, Kalyana-Sundaram S, Udager AM, Roh M, Alva A, Pan J, Lonigro RJ, Siddiqui J, Weizer A, Lee C, Cao X, Wu YM, Robinson DR, Dhanasekaran SM, Chinnaiyan AM. Mehra R, et al. Among authors: alva a. Am J Pathol. 2014 Mar;184(3):584-91. doi: 10.1016/j.ajpath.2013.11.023. Epub 2014 Jan 3. Am J Pathol. 2014. PMID: 24389164 Free PMC article.

9

Intermittent androgen deprivation therapy in advanced prostate cancer.

Alva A, Hussain M. Alva A, et al. Curr Treat Options Oncol. 2014 Mar;15(1):127-36. doi: 10.1007/s11864-013-0272-2. Curr Treat Options Oncol. 2014. PMID: 24395278 Review.

10

Current and proposed molecular diagnostics in a genitourinary service line laboratory at a tertiary clinical institution.

Udager AM, Alva A, Mehra R. Udager AM, et al. Among authors: alva a. Cancer J. 2014 Jan-Feb;20(1):29-42. doi: 10.1097/PPO.0000000000000017. Cancer J. 2014. PMID: 24445763 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters